Long-term follow-up of non-Hodgkin's lymphoma patients treated with radiotherapy
Author Information
Author(s): B. Vaughan Hudson, G. Vaughan Hudson, K.A. MacLennan, L. Anderson, D.C. Linch
Primary Institution: The British National Lymphoma Investigation, University College London School of Medicine
Hypothesis
What are the long-term outcomes of patients with clinical stage 1 non-Hodgkin's lymphoma treated with radiotherapy alone?
Conclusion
Patients with clinical stage 1 non-Hodgkin's lymphoma treated with radiotherapy alone have encouraging long-term survival rates, especially in younger patients.
Supporting Evidence
- 98% of patients with low-grade disease achieved complete remission compared to 84% with high-grade disease.
- Overall cause-specific survival at 10 years was 71% for low-grade and 67% for high-grade disease.
- Patients under 60 years had a 10-year cause-specific survival of 84% for low-grade and 80% for high-grade disease.
Takeaway
Doctors studied 451 patients with a type of cancer called non-Hodgkin's lymphoma and found that those who got radiation treatment did pretty well over time, especially if they were younger.
Methodology
A retrospective analysis of 451 adult patients with clinical stage 1/1E non-Hodgkin's lymphoma treated with radiotherapy alone.
Potential Biases
There may be selection bias due to the multicenter nature of the study.
Limitations
The study did not include patients with certain aggressive types of lymphoma and lacked precise measurements of tumor sizes at diagnosis.
Participant Demographics
The study included 451 adult patients, with 208 having low-grade disease and 243 having high-grade disease; median ages were 59 years for low-grade and 56 years for high-grade.
Statistical Information
P-Value
p<0.0001
Confidence Interval
90% confidence interval 76-86%
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website